Generated by AI
Iridex Corp. is an ophthalmic medical technology company that develops, manufactures, and markets laser-based medical systems, delivery devices, and consumable instrumentation for eye care professionals. The company’s products are used in the treatment of glaucoma, retinal disorders, diabetic eye disease, and other sight-threatening conditions, supporting both office-based procedures and surgical settings. Iridex’s portfolio includes laser consoles, delivery platforms, and single-use probes designed to work with its proprietary MicroPulse technology and other treatment systems. The company serves ophthalmologists, hospitals, surgical centers, research institutions, veterinary practices, and clinics through direct sales in the United States and distributor networks internationally. Headquartered in Mountain View, California, and founded in 1989, Iridex plays a specialized role in the medical device market by providing tools focused on precision ophthalmic therapy and recurring consumable use.
Website1212 Terra Bella Avenue
Mountain View, CA, 94043
United States
The latest articles about IRIX.
Summary of Oct 7's posts. Generated by AI.
Summary of Apr 8's posts. Generated by AI.
Summary of Oct 7's posts. Generated by AI.
Investors talking about IRIX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.